期刊
JOURNAL OF CLINICAL INVESTIGATION
卷 123, 期 3, 页码 1005-1006出版社
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI68417
关键词
-
资金
- NHLBI [HL108794, HL102292, HL53949]
- NIAID [AI077439]
- Scleroderma Research Foundation
- Biogen/Idec
Clinical vignette: A 76-year-old man consults you for increasing shortness of breath over the past two years and an increasing requirement for home oxygen. A video-assisted thoracoscopic lung biopsy shows findings of usual interstitial pneumonitis, and he has no identifiable cause for pulmonary fibrosis, so he is considered to have idiopathic pulmonary fibrosis (IPF). His diffusing capacity for carbon monoxide (DLCO) is 45% of predicted, and his total lung capacity is 40% of predicted. Because of his advanced age, he is not considered a candidate for lung transplantation. What treatment should you recommend?
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据